CGEN-857 [1833]



CGEN-857


SMILES CSCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
InChIKey HPWUNEYLOMSFEY-HVUBXCGRSA-N
Sequence SMCHRWSRAVLFPAAHRP
HELM PEPTIDE1{S.M.C.H.R.W.S.R.A.V.L.F.P.A.A.H.R.P}$$$$

Chemical Properties

Hydrogen bond acceptors 28
Hydrogen bond donors 29
Rotatable bonds 62
Log P -7.859
Molecular weight (Da) 2121.1
Stereochemistry info unspecified

Database connections

Model (AF2) MAS1


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

CGEN-857


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) MAS1


Compound is not listed as a drug.